Education
About Us
Working with TipRanks
Follow Us
Julie Mchugh Insider Profile
4 Followers
Julie Mchugh, Director at Ironwood Pharma, holds 208.84K shares in Ironwood Pharma (Ticker: IRWD), holds 25.96K shares in Lantheus (Ticker: LNTH), holds ― shares in Evelo Biosciences (Ticker: EVLO).
Julie Mchugh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Julie Mchugh holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Julie Mchugh
Julie Mchugh's Trading History
Ironwood Pharma
Jun 12, 2025
Director
Uninformative Buy
―
$781.06K
Lantheus
Jun 11, 2025
Director
Uninformative Sell
423.77K
$2.02M
Evelo Biosciences
―
Director
―
―
Aerie Pharma
Nov 21, 2022
―
Uninformative Sell
245.45K
$0.00
Trevena
―
Director
―
$0.00
Viropharma
Jan 28, 2014
―
Uninformative Sell
433.30K
―
Epirus Biopharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Julie Mchugh's performance on stock
You May Also Like
Julie Mchugh insider profile FAQ
What is the percentage of profitable transactions made by Julie Mchugh?
The percentage of profitable transactions made by Julie Mchugh is ―.
What is the average return per transaction made by Julie Mchugh?
The average return per transaction made by Julie Mchugh is ―.
What stocks does Julie Mchugh hold?
Julie Mchugh holds: IRWD, LNTH, EVLO, AERI, TRVN, VPHM, EPRSQ stocks.
What was Julie Mchugh’s latest transaction?
Julie Mchugh latest transaction was an Uninformative Buy of ―.
What was Julie Mchugh's most profitable transaction?
Julie Mchugh’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Julie Mchugh's role in Ironwood Pharma?
Julie Mchugh's role in Ironwood Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.